Dina Brady Anderson

Title: Innovations of Dina Brady Anderson

Introduction

Dina Brady Anderson is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of engineered clostridial toxins. With a total of six patents to her name, her work has implications for medical applications and toxin purification methods.

Latest Patents

One of her latest patents focuses on cationic neurotoxins. This invention provides engineered clostridial toxins that include at least one amino acid modification. This modification increases the isoelectric point (pi) of the engineered clostridial toxin to a value that is at least 0.2 pi units higher than that of an otherwise identical clostridial toxin lacking the modification. Importantly, the modification is not located in the clostridial toxin binding domain (H-domain). Additionally, she has developed methods for purifying clostridial neurotoxins, which involve contacting a cation exchange resin with a composition comprising the neurotoxin at a pH of at least 7.3.

Career Highlights

Dina has worked with notable companies such as Ipsen Bioinnovation Limited and Ipsen Biopharm Limited. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in her field.

Collaborations

Throughout her career, Dina has collaborated with esteemed colleagues, including Gavin Stephen Hackett and Sai Man Liu. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Dina Brady Anderson is a trailblazer in the field of biotechnology, with a focus on engineered clostridial toxins and purification methods. Her contributions are paving the way for advancements in medical applications and toxin research.